走进诺和诺德 更多 >>
诺和诺德是一家致力于人类健康、以先进的生物技术造福患者、医生和社会的世界领先生物制药公司。
诺和诺德公司的历史最早可追溯至1923年，80多年来一直是世界糖尿病研究和药物开发领域的主导。诺和诺德总部位于丹麦首都哥本哈根，现在全球79个国家设有分支机构，6个国家设有生产厂，截至08年底，员工超过 27，000名，销售遍及180个国家。
诺和诺德凭借自身的研发实力成为世界糖尿病治疗领域先导，在行业内拥有最为广泛的糖尿病治疗产品，其中包括最先进的胰岛素给药系统产品。
德国Fachklinik糖尿病代谢中心医学主任Andreas Liebl教授
Andreas Liebl
Bad Heilbrunn, Germany
Andreas Liebl has been Medical Director of the Centre for Diabetes and Metabolism at the Fachklinik in Bad Heilbrunn since the year 2000. He is Vice President of the Working Group ‘Diabetes Technology – Insulin Pumps and Blood Glucose Sensors’ of the Germany Diabetes Association (DDG), and was on the Scientific Board of the AIDPIT group at the European Association for the Study of Diabetes (EASD).
He is currently serving as one of the chairmen of the Bavarian Diabetes Committee at the DDG. Dr Liebl has prepared numerous international and national publications and presentations at scientific meetings, mainly on the topics of insulin therapy, oral antidiabetic drugs, pharmacoeconomics, insulin pump therapy, diabetic foot syndrome and intraperitoneal insulin therapy.
编辑: xiaoyan 作者:丁香园通讯员
以下网友留言只代表网友个人观点，不代表网站观点
